Literature DB >> 12928916

Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy.

Alexander J Radziwill1, Andreas J Steck, Susanne Renaud, Peter Fuhr.   

Abstract

There is debate whether the terminal latency index (TLI) is a sensitive marker for polyneuropathy with anti-myelin-associated-glycoprotein antibodies (anti-MAGP). We examined 6 patients with an anti-MAGP and 6 patients with a chronic inflammatory demyelinating polyneuropathy (CIDP). The electroneurographic features studied were: distal compound motor action potential (CMAP), distal motor latency (DML), motor conduction velocity (MCV) elbow to wrist (distal MCV), MCV axilla to elbow (proximal MCV), MCV distal/proximal, terminal latency index (TLI), residual latency (RL), F-wave, and modified F ratio. We found significant differences between anti-MAGP and CIDP for DML and for RL. No significant differences were found for TLI and the other measures. The TLI values were not significant probably because our patients had a longer duration of disease,which supports the hypothesis of a distal to proximal progression of conduction slowing over time. We propose that a residual latency >4.0 and a distal motor latency >7.0 are strongly suggestive for an anti- MAGP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928916     DOI: 10.1007/s00415-003-1128-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

Review 1.  Inflammatory neuropathies.

Authors:  Hannah R Briemberg; Anthony A Amato
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

2.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

3.  Diagnostic performance of two-dimensional shear wave elastography for evaluating tibial nerve stiffness in patients with diabetic peripheral neuropathy.

Authors:  Weixi Jiang; Sirun Huang; Hua Teng; Peipei Wang; Meng Wu; Xia Zhou; Weiwei Xu; Qunxia Zhang; Haitao Ran
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

4.  The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.

Authors:  Christopher J Klein; Joon-Shik Moon; Michelle L Mauermann; Steven R Zeldenrust; Yanhong Wu; Angela Dispenzieri; Peter J Dyck
Journal:  Can J Neurol Sci       Date:  2011-03       Impact factor: 2.104

5.  Value of shear wave elastography combined with the Toronto clinical scoring system in diagnosis of diabetic peripheral neuropathy.

Authors:  Fei Wang; Miao Zheng; Ji Hu; Chen Fang; Tong Chen; Meng Wang; Honghong Zhang; Yunyan Zhu; Xin Song; Qi Ma
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

6.  Clinical utility of residual latency in ulnar neuropathy at elbow: Is there any correlation?

Authors:  Saeid Khosrawi; Farnaz Dehghan; Vahid Shaygannejad
Journal:  Adv Biomed Res       Date:  2015-01-30

Review 7.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

8.  Quantification of Nerve Viscosity Using Shear Wave Dispersion Imaging in Diabetic Rats: A Novel Technique for Evaluating Diabetic Neuropathy.

Authors:  Feifei Liu; Diancheng Li; Yuwei Xin; Fang Liu; Wenxue Li; Jiaan Zhu
Journal:  Korean J Radiol       Date:  2022-01-04       Impact factor: 3.500

9.  Rituximab Improves Subclinical Temporal Dispersion of Distal Compound Muscle Action Potential in Anti-MAG/SGPG Neuropathy Associated with Waldenström Macroglobulinemia: A Case Report.

Authors:  Minori Kodaira; Kanji Yamamoto
Journal:  Case Rep Neurol       Date:  2013-02-19

10.  Determination of the median nerve residual latency values in the diagnosis of carpal tunnel syndrome in comparison with other electrodiagnostic parameters.

Authors:  Saeid Khosrawi; Farnaz Dehghan
Journal:  J Res Med Sci       Date:  2013-11       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.